Apogee Therapeutics (APGE) Interest Income - Net (2024 - 2025)
Apogee Therapeutics' (APGE) quarterly Interest Income - Net came in at -$224.9 million in Q4 2025, down 220.43% year-on-year from $186.7 million in Q4 2024, and down 347.55% on a QoQ basis from -$50.3 million in Q3 2025.
Apogee Therapeutics (APGE) Interest Income - Net (2024 - 2025) Analysis & Trends
Apogee Therapeutics (APGE) has 2 years of Interest Income - Net data on file, last reported at -$224.9 million in Q4 2025.
- On a quarterly basis, Interest Income - Net fell 220.43% year-over-year to -$224.9 million in Q4 2025; TTM through Dec 2025 was -$347.4 million, a 63.78% decrease from a year earlier, with the FY2025 full-year figure at -$246.2 million, down 122.15% from the prior year.
- Interest Income - Net for Q4 2025 stood at -$224.9 million, down from -$50.3 million in the prior quarter.
- Over the last five years, Interest Income - Net for APGE reached as high as -$7.9 million in Q1 2025 and fell as low as -$224.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Net (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -17.04 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Apogee Therapeutics | 9.35 Bn | 8.29 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -224.90 Mn |
| Sep 30, 2025 | -50.25 Mn |
| Jun 30, 2025 | -64.34 Mn |
| Mar 31, 2025 | -7.88 Mn |
| Dec 31, 2024 | -70.19 Mn |
| Sep 30, 2024 | -9.77 Mn |
| Jun 30, 2024 | -10.35 Mn |
| Mar 31, 2024 | -121.78 Mn |